BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Q, Dai X, Zhang H, Zeng Y, Luo K, Li W. Recent advances in development of nanomedicines for multiple sclerosis diagnosis. Biomed Mater 2021;16:024101. [PMID: 33472182 DOI: 10.1088/1748-605X/abddf4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Damavandi AR, Mirmosayyeb O, Ebrahimi N, Zalpoor H, khalilian P, Yahiazadeh S, Eskandari N, Rahdar A, Kumar PS, Pandey S. Advances in nanotechnology versus stem cell therapy for the theranostics of multiple sclerosis disease. Appl Nanosci 2022. [DOI: 10.1007/s13204-022-02698-x] [Reference Citation Analysis]
2 Zhang Y, Pei R. Editorial: Special issue on advances in nanomedicine. Biomed Mater 2022;17:060202. [DOI: 10.1088/1748-605x/ac8fc9] [Reference Citation Analysis]
3 Nuzzo D, Picone P. Multiple Sclerosis: Focus on Extracellular and Artificial Vesicles, Nanoparticles as Potential Therapeutic Approaches. Int J Mol Sci 2021;22:8866. [PMID: 34445572 DOI: 10.3390/ijms22168866] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]